Annovis Bio, Inc. Share Price
NYSE: ANVS$0.00
+0.00 (0.00%) Annovis Bio, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Annovis Bio, Inc. Share Price Chart
$0.00$0.00
L
H
Annovis Bio, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-1.40 | Revenue (TTM) N/A | Return On Equity (TTM) -171.23% |
Profit Margin N/A | Debt to Equity 0.22 | Quarterly Earnings Growth YoY 42.53% |
Annovis Bio, Inc. Quarterly Profit & Loss
All figures in USD
Annovis Bio, Inc. Annual Profit & Loss
All figures in USD
About Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Annovis Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
ANVS Share Price FAQs
What is Annovis Bio, Inc. share price today?
Annovis Bio, Inc. share price today is $0.00 as on August 9, 2026 at 12:13 am IST.
What is the 52 week high and 52 week low of Annovis Bio, Inc. stock?
52 week high/low data for Annovis Bio, Inc. is currently unavailable.
What is ANVS's net income for the last quarter?
ANVS's net income for the last quarter is -0.01B USD.
Can I buy ANVS shares in India?
Yes. You can buy ANVS in India by opening an international trading account.